{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:21:28Z","timestamp":1761823288533},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.ijrobp.2010.06.017","type":"journal-article","created":{"date-parts":[[2010,10,2]],"date-time":"2010-10-02T08:53:38Z","timestamp":1286009618000},"page":"745-750","source":"Crossref","is-referenced-by-count":8,"title":["Predictors of Urinary Morbidity in Cs-131 Prostate Brachytherapy Implants"],"prefix":"10.1016","volume":"81","author":[{"given":"Ryan P.","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather A.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushil","family":"Beriwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhay","family":"Gokhale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2010.06.017_bib1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0360-3016(01)01601-7","article-title":"10-year biochemical (prostate-specific antigen) control of prostate cancer with I-125 brachytherapy","volume":"51","author":"Grimm","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.06.017_bib2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0360-3016(03)00627-8","article-title":"Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: Importance of patient selection and implant quality","volume":"57","author":"Kollmeier","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.06.017_bib3","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/01.ju.0000154633.73092.8e","article-title":"12-year outcomes following permanent prostate brachytherapy in patients with classically localized prostate cancer","volume":"173","author":"Potters","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2010.06.017_bib4","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.urology.2009.04.060","article-title":"Urinary side effects and complications after permanent prostate brachytherapy: The M.D. Anderson Cancer Center experience","volume":"74","author":"Anderson","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.ijrobp.2010.06.017_bib5","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ijrobp.2008.05.022","article-title":"Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: long-term outcome in 712 consecutive patients","volume":"73","author":"Keyes","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.06.017_bib6","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ijrobp.2005.03.046","article-title":"Quality of life of patients after permanent prostate brachytherapy in relation to dosimetry","volume":"63","author":"Van Gellekom","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.06.017_bib7","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1200\/JCO.2003.01.199","article-title":"Time course and predictors of symptoms after primary prostate cancer therapy","volume":"21","author":"Talcott","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.06.017_bib8","doi-asserted-by":"crossref","unstructured":"Jacobs BL, Smith RP, Beriwal S, Benoit RM. Acute lower urinary tract symptoms after prostate brachytherapy with Cesium-131. Urology. Urology 2010, June 3 [epub ahead of print].","DOI":"10.1016\/j.urology.2009.12.084"},{"key":"10.1016\/j.ijrobp.2010.06.017_bib9","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0090-4295(00)00858-X","article-title":"Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer","volume":"56","author":"Wei","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.ijrobp.2010.06.017_bib10","unstructured":"IsoRay Medical Inc. CS-131 product information sheet. Available at: http:\/\/www.isoray.com\/."},{"key":"10.1016\/j.ijrobp.2010.06.017_bib11","unstructured":"Kinsey RR. The NuDat program for nuclear data on the web. National Nuclear Data Center, Brookhaven National Laboratory. Available at: http:\/\/www.nndc.bnl.gov\/nndc\/nudat\/."},{"key":"10.1016\/j.ijrobp.2010.06.017_bib12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1118\/1.597458","article-title":"Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43","volume":"22","author":"Nath","year":"1995","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2010.06.017_bib13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1200\/JCO.1998.16.1.275","article-title":"Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study","volume":"16","author":"Talcott","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.06.017_bib14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0360-3016(99)00525-8","article-title":"Temporal resolution of urinary morbidity following prostate brachytherapy","volume":"47","author":"Merrick","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.06.017_bib15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.brachy.2007.03.003","article-title":"The nature and extent of urinary morbidity in relation to prostate brachytherapy urethral dosimetry","volume":"6","author":"Neill","year":"2007","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijrobp.2010.06.017_bib16","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.urology.2006.10.001","article-title":"Long-term urinary, sexual, and rectal morbidity in patients treated with I-125 prostate brachytherapy followed up for a minimum of 5 years","volume":"69","author":"Stone","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.ijrobp.2010.06.017_bib17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.juro.2007.08.136","article-title":"Long-term urinary sequelae following 125iodine prostate brachytherapy","volume":"179","author":"Crook","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2010.06.017_bib18","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijrobp.2005.06.035","article-title":"The influence of isotope and prostate volume on urinary morbidity after prostate brachytherapy","volume":"64","author":"Niehaus","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.06.017_bib19","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ijrobp.2004.12.068","article-title":"Detailed urethral dosimetry in the evaluation of prostate brachytherapy-related urinary morbidity","volume":"62","author":"Allen","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.06.017_bib20","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.clon.2006.02.007","article-title":"Prediction of urinary symptoms after 125iodine prostate brachytherapy","volume":"18","author":"Kelly","year":"2006","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2010.06.017_bib21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0360-3016(00)00433-8","article-title":"Urinary morbidity with a modified peripheral loading technique of transperineal (125)I prostate implantation","volume":"47","author":"Brown","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.06.017_bib22","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0360-3016(94)00599-G","article-title":"Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy","volume":"32","author":"Wallner","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.06.017_bib23","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0360-3016(02)04600-X","article-title":"Long-term urinary quality of life following permanent prostate brachytherapy","volume":"56","author":"Merrick","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.06.017_bib24","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJMoa074311","article-title":"Quality of life and satisfaction with outcome among prostate-cancer survivors","volume":"358","author":"Sanda","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ijrobp.2010.06.017_bib25","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ijrobp.2006.05.072","article-title":"Changing the patterns of failure for high-risk prostate cancer patients by optimizing local control","volume":"66","author":"Stock","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.06.017_bib26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/1097-0142(20000701)89:1<135::AID-CNCR18>3.0.CO;2-#","article-title":"Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up","volume":"89","author":"Ragde","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2010.06.017_bib27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.brachy.2006.09.004","article-title":"Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: A survey of practice patterns in the United States","volume":"6","author":"Frank","year":"2007","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijrobp.2010.06.017_bib28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0360-3016(99)00176-5","article-title":"Urinary morbidity following ultrasound-guided transperineal prostate seed implantation","volume":"45","author":"Gelblum","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.06.017_bib29","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1464-410X.2004.4737h.x","article-title":"Urinary morbidity after 125I brachytherapy of the prostate","volume":"93","author":"Henderson","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.ijrobp.2010.06.017_bib30","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0360-3016(01)02657-8","article-title":"Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: A prospective study","volume":"52","author":"Locke","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.06.017_bib31","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0022-5347(01)62542-4","article-title":"Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate","volume":"160","author":"Terk","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2010.06.017_bib32","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ijrobp.2007.12.052","article-title":"Segmental urethral dosimetry and urinary toxicity in patients with no urinary symptoms prior to permanent prostate brachytherapy","volume":"72","author":"Thomas","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"24","key":"10.1016\/j.ijrobp.2010.06.017_bib33","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1200\/JCO.2008.18.6486","article-title":"Individualizing quality-of-life outcomes reporting: How localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function","volume":"27","author":"Chen","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301610008667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301610008667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T05:31:43Z","timestamp":1559712703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301610008667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0360301610008667"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2010.06.017","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}